| 产品标题 |
产品货号 |
产品规格 |
厂家 |
| GABRG1 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN406307 | 1 kit | ORIGENE TECHNOLOGIES |
| Gabrg1 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN506247 | 1 kit | ORIGENE TECHNOLOGIES |
| Gabrg2 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN506248 | 1 kit | ORIGENE TECHNOLOGIES |
| Gabrg3 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN506249 | 1 kit | ORIGENE TECHNOLOGIES |
| GABRP - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN224902 | 1 kit | ORIGENE TECHNOLOGIES |
| GABRP - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN224902BN | 1 kit | ORIGENE TECHNOLOGIES |
| GABRP - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN224902RB | 1 kit | ORIGENE TECHNOLOGIES |
| Gad2 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN506256 | 1 kit | ORIGENE TECHNOLOGIES |
| GADL1 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN410803 | 1 kit | ORIGENE TECHNOLOGIES |
| Gadl1 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN506261 | 1 kit | ORIGENE TECHNOLOGIES |
| GAD1 Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH307226 | 10 ug | ORIGENE TECHNOLOGIES |
| GAD2 Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH323464 | 10 ug | ORIGENE TECHNOLOGIES |
| GABRP - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN224902LP | 1 kit | ORIGENE TECHNOLOGIES |
| GAD2 Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH325984 | 10 ug | ORIGENE TECHNOLOGIES |
| GAGE2A - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN425045 | 1 kit | ORIGENE TECHNOLOGIES |
| GAGE12B - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN425047 | 1 kit | ORIGENE TECHNOLOGIES |
| GAGE2B Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH314744 | 10 ug | ORIGENE TECHNOLOGIES |
| GAGE2B - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN414744 | 1 kit | ORIGENE TECHNOLOGIES |
| GAGE2C - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN418241 | 1 kit | ORIGENE TECHNOLOGIES |
| GAGE12C - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN421088 | 1 kit | ORIGENE TECHNOLOGIES |
| GAGE2D - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN421614 | 1 kit | ORIGENE TECHNOLOGIES |
| GAGE12D - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN425046 | 1 kit | ORIGENE TECHNOLOGIES |
| GAGE2C Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH318241 | 10 ug | ORIGENE TECHNOLOGIES |
| GAGE12E - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN420185 | 1 kit | ORIGENE TECHNOLOGIES |
| GAGE2E - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN425043 | 1 kit | ORIGENE TECHNOLOGIES |
| GAGE12F - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN418092 | 1 kit | ORIGENE TECHNOLOGIES |
| GAGE12G - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN414377 | 1 kit | ORIGENE TECHNOLOGIES |
| GAGE12H - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN414378 | 1 kit | ORIGENE TECHNOLOGIES |
| GAGE12J - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN418555 | 1 kit | ORIGENE TECHNOLOGIES |
| GAGE7 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN404459 | 1 kit | ORIGENE TECHNOLOGIES |
| GAGE12I - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN411909 | 1 kit | ORIGENE TECHNOLOGIES |
| GAGE1 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN406299 | 1 kit | ORIGENE TECHNOLOGIES |
| GAGE5 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN412463 | 1 kit | ORIGENE TECHNOLOGIES |
| Human v-erb-a erythroblastic leukemia viral oncogene homolog 4 (avian) (ERBB4), transcript variant JM-a/CVT-2, full length from ORIGENE TECHNOLOGIES | TP710090 | 20 ug | ORIGENE TECHNOLOGIES |
| Human v-erb-a erythroblastic leukemia viral oncogene homolog 4 (avian) (ERBB4), transcript variant JM-a/CVT-2, residues 26-651 from ORIGENE TECHNOLOGIES | TP710093 | 20 ug | ORIGENE TECHNOLOGIES |
| Human v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) (ERBB3), transcript variant 1 from ORIGENE TECHNOLOGIES | TP309954 | 20 ug | ORIGENE TECHNOLOGIES |
| Human v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) (ERBB3), transcript variant 1 from ORIGENE TECHNOLOGIES | TP700106 | 20 ug | ORIGENE TECHNOLOGIES |
| Human v-erb-a erythroblastic leukemia viral oncogene homolog 4 (avian) (ERBB4), transcript variant JM-a/CVT-2 from ORIGENE TECHNOLOGIES | TP320500 | 20 ug | ORIGENE TECHNOLOGIES |
| Human v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) (ERBB3), transcript variant 1, residues 20-643 from ORIGENE TECHNOLOGIES | TP710091 | 20 ug | ORIGENE TECHNOLOGIES |
| Human v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) (ERBB2), full length from ORIGENE TECHNOLOGIES | TP710032 | 20 ug | ORIGENE TECHNOLOGIES |
| Human v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) (ERBB3), transcript variant 1, full length from ORIGENE TECHNOLOGIES | TP710089 | 20 ug | ORIGENE TECHNOLOGIES |
| Human v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) (ERBB2), residues 23-652aa from ORIGENE TECHNOLOGIES | TP710036 | 20 ug | ORIGENE TECHNOLOGIES |
| Human v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) (ERBB2), transcript variant 1 from ORIGENE TECHNOLOGIES | TP312583 | 20 ug | ORIGENE TECHNOLOGIES |
| Human v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) (ERBB3), transcript variant s from ORIGENE TECHNOLOGIES | TP324398 | 20 ug | ORIGENE TECHNOLOGIES |
| Human v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) (ERBB2), residues 676-1255aa from ORIGENE TECHNOLOGIES | TP710004 | 20 ug | ORIGENE TECHNOLOGIES |
| Human v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) (ERBB2), transcript variant 2 from ORIGENE TECHNOLOGIES | TP322909 | 20 ug | ORIGENE TECHNOLOGIES |
| Human v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) (ERBB2), transcript variant 1, full length from ORIGENE TECHNOLOGIES | TP790102 | 50 ug | ORIGENE TECHNOLOGIES |
| Human v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) (ERBB2), transcript variant 1, extracellular domain from ORIGENE TECHNOLOGIES | TP700105 | 20 ug | ORIGENE TECHNOLOGIES |
| Human Vertebra; Spondylosis from ORIGENE TECHNOLOGIES | CS606837 | 5x5um | ORIGENE TECHNOLOGIES |
| Human vesicle amine transport protein 1 homolog (T. californica) (VAT1) from ORIGENE TECHNOLOGIES | TP302201 | 20 ug | ORIGENE TECHNOLOGIES |